Fry John A's Form 4 filing

vTv Therapeutics Inc. (VTVT) · filed Nov 30, 2022

Accession no.: 0000950142-22-003282
Filed: Nov 30, 2022
Trade date: Nov 28-29, 2022
Filing delay: 2 days
Rule 10b5-1 plan: Not on the form (before 2023)

Original on SEC EDGAR (opens in a new tab)

This filing lists 2 non-derivative transactions. Open-market purchases total $50.6K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
Owner	Relationship to the company
Fry John ACIK 0001255140	Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade date	Security	Transaction	Shares	Price	Value	Shares after	Ownership	Flags
Nov 28, 2022	Class A common stock	PPurchaseAcquired	+20,539	$0.83^F1	+$17,047.37	20,539	Direct
Nov 29, 2022	Class A common stock	PPurchaseAcquired	+40,461	$0.83^F2	+$33,582.63	61,000	Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

The price reported in column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.805 to $0.8487, inclusive. The reporting person undertakes to provide to vTv Therapeutics Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote to this Form 4.

Referenced by the price of 1 transaction in Table I.

The price reported in column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.81 to $0.849, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote to this Form 4.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)